Johnson Matthey (LON:JMAT - Get Free Report) had its price objective lifted by equities research analysts at Berenberg Bank from GBX 1,950 to GBX 2,100 in a research report issued on Thursday,
Digital Look reports. The firm presently has a "hold" rating on the stock. Berenberg Bank's price target would suggest a potential upside of 1.51% from the stock's current price.
Johnson Matthey Stock Up 0.0%
JMAT traded up GBX 0.74 during trading on Thursday, reaching GBX 2,068.74. The stock had a trading volume of 322,726 shares, compared to its average volume of 1,804,208. Johnson Matthey has a one year low of GBX 1,131 and a one year high of GBX 2,112. The company has a market capitalization of £3.47 billion, a price-to-earnings ratio of 979.52, a P/E/G ratio of 49,242.50 and a beta of 0.95. The stock's 50 day moving average is GBX 1,906.01 and its two-hundred day moving average is GBX 1,668.91. The company has a current ratio of 1.45, a quick ratio of 0.76 and a debt-to-equity ratio of 62.73.
Insider Activity at Johnson Matthey
In other Johnson Matthey news, insider Andrew Cosslett acquired 10,495 shares of the company's stock in a transaction that occurred on Tuesday, August 26th. The shares were bought at an average cost of GBX 1,896 per share, with a total value of £198,985.20. 0.50% of the stock is owned by company insiders.
Johnson Matthey Company Profile
(
Get Free Report)
Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers' products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet's natural resources.
See Also
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Johnson Matthey, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Johnson Matthey wasn't on the list.
While Johnson Matthey currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.